Gladys Nunez, MS, is an experienced early stage investor with two decades of experience supporting opportunities and alliances with health venture groups and organizations.
Ms. Nunez has been Principal of Amgen Ventures since 2014 where she currently leads diligence on new venture opportunities, working closely with Amgen’s Digital Health Organization. Since joining Amgen in 1997 as a biochemist, she has held various roles within the company including managing Amgen’s Academic Alliance Group, an initiative to build bridges between academia and industry through the establishment of comprehensive academic alliances. In 2002, she transferred into business development where she has completed numerous deals focused on discovery, development, and commercial applications in life sciences. She began her career as a biochemist for AstraZeneca.
Ms. Nunez holds a bachelor’s degree in biology/pre-med from Marist College and a master’s degree in biochemical pharmacology from the University of Southampton.